Arcellx (ACLX)
(Delayed Data from NSDQ)
$71.14 USD
-0.25 (-0.35%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $71.13 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACLX 71.14 -0.25(-0.35%)
Will ACLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACLX
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates
ACLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
5 Biotech Breakthrough Stocks to Watch in 2025
Other News for ACLX
Arcellx (ACLX) Price Target Boosted by Scotiabank
Arcellx price target raised by $40 at Scotiabank, here's why
4 Analysts Assess Arcellx: What You Need To Know
Scotiabank Raises Price Target for ACLX to $133 While Maintaining Sector Outperform Rating | ...
Bullish Two Hundred Day Moving Average Cross - ACLX